Splice-inhibition therapy targets progeria
Nat Med
.
2021 Mar;27(3):377-379.
doi: 10.1038/s41591-021-01267-z.
Authors
Gwladys Revêchon
1
,
Daniel Whisenant
1
,
Maria Eriksson
2
Affiliations
1
Karolinska Institutet, Department of Biosciences and Nutrition, Center for Innovative Medicine, Huddinge, Sweden.
2
Karolinska Institutet, Department of Biosciences and Nutrition, Center for Innovative Medicine, Huddinge, Sweden. maria.eriksson.2@ki.se.
PMID:
33707774
DOI:
10.1038/s41591-021-01267-z
No abstract available
Publication types
Comment
MeSH terms
Humans
Lamin Type A / genetics
Mutation / genetics
Oligonucleotides, Antisense
Progeria* / genetics
Substances
Lamin Type A
Oligonucleotides, Antisense